What is the most accurate method to determine initial tumor size prior to neoadjuvant chemotherapy and mastectomy?   

Do you look at pretreatment breast MRI or post surgical assessment of the tumor bed/treatment effect?  How would you resolve discrepancies between the two (MRI suggests initial T3 disease but path shows 2 cm treatment effect)?



Answer from: Radiation Oncologist at Community Practice